← ANALYSTS · TIPRANKS
Daniil Gataulin · Chardan Capital
Hits
39%
26 of 67 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+14.9%
Over a year after the rating, TipRanks’ measure
Our companies rated now
9
Buy / hold / sell: 9 / 0 / 0
Upside of the analyst’s targets
+353.4%
Average over 9 current targets, to the last price
The market’s answer to the ratings
−0.4%
Day-0 move against SPY in the rating’s direction, average over 4 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Jun 25on TipRanks 06:31 | OCULIWMOcular Therapeutix · $1.6B | Reiterated | Buy | $21.00 → $23.00+9.5% | +234.8% | −1.1%next day +1.5% · 5 days −2.7% | ↗ |
| May 14on TipRanks 18:10 | MGTXIWMMeiragtx Holdings · $950M | Reiterated | Buy | $35.00 | +277.2% | −4.3%next day +0.1% · 5 days −2.6% | ↗ |
| May 12on TipRanks 02:50 | OCSOculis Holding · $486M | Reiterated | Buy | $53.00 | +627.0% | −6.7%next day +2.6% · 5 days −7.5% | ↗ |
| May 11on TipRanks 08:10 | KODIWMKodiak Sciences · $5.5B | Upgrade | Buy | $61.00 | −28.9% | −3.1%next day −0.8% · 5 days −12.0% | ↗ |
| May 7on TipRanks 18:30 | ZURAIWMZura Bio · $423M | Reiterated | Buy | $4.89 → $11.00+124.9% | +183.5% | +4.7%next day −1.1% · 5 days −1.7% | ↗ |
| May 7on TipRanks 08:30 | OCGNIWMOcugen · $276M | Reiterated | Buy | $7.00 | +797.4% | −0.7%next day +4.0% · 5 days −0.9% | ↗ |
| May 5on TipRanks May 6 00:11 | QUREuniQure · $1.5B | Reiterated | Buy | $37.00 | +69.9% | +1.5%next day +6.5% · 5 days +35.5% | ↗ |
| Jan 28on TipRanks 18:10 | RGNXIWMRegenXBio · $473M | Reiterated | Buy | $52.00 | +650.9% | +5.6%next day −3.5% · 5 days −9.2% | ↗ |
| Dec 23on TipRanks 04:30 | ANNXIWMAnnexon Biosciences · $682M | Initiated | Buy | $16.00 | +369.2% | −2.0%next day +1.0% · 5 days −0.9% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗